Discovery and Characterization of Novel Antibodies Targeting the Asialoglycoprotein Receptor for Tissue-Specific Protein Degradation and Wnt Signaling Enhancement
Novel antibodies targeting the asialoglycoprotein receptor (ASGR) can be used to develop a targeted protein degradation platform that enhances Wnt signaling in a tissue-specific manner.